Cargando…
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease in high-income countries and is associated with increased morbidity and mortality. Macrophages appear to play an important role in the development and progression of hepatic fibrosis in patients with NAFLD. Accordingly,...
Autores principales: | Neokosmidis, Georgios, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319130/ https://www.ncbi.nlm.nih.gov/pubmed/30622370 http://dx.doi.org/10.3748/wjg.v24.i48.5415 |
Ejemplares similares
-
Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
por: Tsankof, Alexandra, et al.
Publicado: (2022) -
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016) -
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
por: Kontana, Anastasia, et al.
Publicado: (2019) -
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020) -
Novel insights in the prevention of perinatal transmission of hepatitis B
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)